Rohit Sukumar
Overview
Explore the profile of Rohit Sukumar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
288
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sukumar R, Ko A, Dueck N, Patel S
Neuroradiol J
. 2023 Apr;
:19714009231173107.
PMID: 37105945
Diffuse gliomas are the most common primary malignant brain tumors in adults. Advancements in the molecular profiling of diffuse gliomas in recent years have led to a far better understanding...
2.
Della Rocca J, Werner M, Kramer S, Huxford-Phillips R, Sukumar R, Cummings N, et al.
Nanomedicine
. 2014 Jul;
11(1):31-8.
PMID: 25038495
Chemoradiotherapy is a well-established treatment paradigm in oncology. There has been strong interest in identifying strategies to further improve its therapeutic index. An innovative strategy is to utilize nanoparticle (NP)...
3.
Sethi M, Sukumar R, Karve S, Werner M, Wang E, Moore D, et al.
Nanoscale
. 2014 Jan;
6(4):2321-2327.
PMID: 24418914
The effects of nanoparticle (NP) properties, such as size, shape and surface charge, on their efficacy and toxicity have been studied extensively. However, the effect of controlled drug release on...
4.
Werner M, Cummings N, Sethi M, Wang E, Sukumar R, Moore D, et al.
Int J Radiat Oncol Biol Phys
. 2013 May;
86(3):463-468.
PMID: 23708084
Purpose: A key research objective in radiation oncology is to identify agents that can improve chemoradiation therapy. Nanoparticle (NP) chemotherapeutics possess several properties, such as preferential accumulation in tumors, that...
5.
Karve S, Werner M, Sukumar R, Cummings N, Copp J, Wang E, et al.
Proc Natl Acad Sci U S A
. 2012 May;
109(21):8230-5.
PMID: 22547809
One of the promises of nanoparticle (NP) carriers is the reformulation of promising therapeutics that have failed clinical development due to pharmacologic challenges. However, current nanomedicine research has been focused...
6.
Werner M, Copp J, Karve S, Cummings N, Sukumar R, Li C, et al.
ACS Nano
. 2011 Oct;
5(11):8990-8.
PMID: 22011071
Nanoparticle (NP) chemotherapeutics hold great potential as radiosensitizers. Their unique properties, such as preferential accumulation in tumors and their ability to target tumors through molecular targeting ligands, are ideally suited...
7.
Karve S, Werner M, Cummings N, Sukumar R, Wang E, Zhang Y, et al.
J Vis Exp
. 2011 Oct;
(55).
PMID: 21968609
Nanotechnology is a relatively new branch of science that involves harnessing the unique properties of particles that are nanometers in scale (nanoparticles). Nanoparticles can be engineered in a precise fashion...
8.
Werner M, Karve S, Sukumar R, Cummings N, Copp J, Chen R, et al.
Biomaterials
. 2011 Aug;
32(33):8548-54.
PMID: 21843904
Peritoneal metastasis is a major cause of morbidity and mortality in ovarian cancer. While intraperitoneal chemotherapy and radiotherapy have shown favorable clinical results, both are limited by their non-targeted nature....